Tech Company Financing Transactions

Marina Biotech Funding Round

Marina Biotech, based in City of Industry, scored $10.5 million from private investors.

Transaction Overview

Company Name
Announced On
6/10/2009
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
17870 Castleton St. 250
City of Industry, CA 91748
USA
Email Address
Overview
Marina Biotech (NASDAQ: MRNA), is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi).
Profile
Marina Biotech LinkedIn Company Profile
Social Media
Marina Biotech Company Twitter Account
Company News
Marina Biotech News
Facebook
Marina Biotech on Facebook
YouTube
Marina Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Moscato
  Robert Moscato LinkedIn Profile  Robert Moscato Twitter Account  Robert Moscato News  Robert Moscato on Facebook
Chief Financial Officer
Amit Shah
  Amit Shah LinkedIn Profile  Amit Shah Twitter Account  Amit Shah News  Amit Shah on Facebook
Chief Operating Officer
Erik Emerson
  Erik Emerson LinkedIn Profile  Erik Emerson Twitter Account  Erik Emerson News  Erik Emerson on Facebook
VP - General Counsel
Peter Weinstein
  Peter Weinstein LinkedIn Profile  Peter Weinstein Twitter Account  Peter Weinstein News  Peter Weinstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/10/2009: Savara Pharmaceuticals venture capital transaction
Next: 6/10/2009: Pique Therapeutics venture capital transaction

 

Share this article

 


News on VC Transactions

We report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary